2 months ago
ABBV
AnalystsDavid RisingerDavid Risinger's Stock Forecasts
AnalystsDavid Risinger
Analyst Ranking
Top 11%
#421 out of 4172 analysts
Average Return
+10.57%
Win Rate
53%27 out of 51
Risk vs Reward
Poor
Good
David Risinger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd CoHZNP | +184.14% | $31.85 | $90.50 | 2020-04-02 - 2021-04-01 | Strong Buy |
Roivant Sciences LtdROIV | +96.71% | $3.65 | $7.18 | 2022-05-23 - 2023-03-27 | Buy |
Eli Lilly & CoLLY | +74.18% | $149.02 | $259.57 | 2020-09-03 - 2021-09-02 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +68.51% | $67.00 | $112.90 | 2022-08-04 - 2022-12-13 | Buy |
Endo International PLCENDPQ | +66.86% | $6.85 | $2.27 | 2021-03-03 - 2022-03-02 | Strong Sell |
David Risinger Analyst Color
Get additional color on David Risinger's coverage of popular stocks
6 months ago
PFE
8 months ago
JNJ
David Risinger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 6 | Buy | $976.00 | +18.96% | Upgrades | a day ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Buy | $6.00 | +56.66% | Initiates Coverage On | 11 days ago |
Halozyme Therapeutics IncHALO | 3 | Hold | $42.00 | +17.65% | Downgrades | 12 days ago |
Abbvie IncABBV | 4 | Hold | $153.00 | -2.88% | Upgrades | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 3 | Buy | $365.00 | +18.33% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 3 | Hold | $91.00 | +14.35% | Maintains | 2 months ago |
Amgen IncAMGN | 3 | Hold | $267.00 | +12.77% | Maintains | 2 months ago |
Pfizer IncPFE | 9 | Hold | $48.00 | +19.34% | Maintains | 2 months ago |
Johnson & JohnsonJNJ | 2 | Buy | $186.00 | +21.33% | Maintains | 2 months ago |
Roivant Sciences LtdROIV | 4 | Buy | $10.00 | +39.28% | Maintains | 3 months ago |
Eli Lilly & CoLLY | 11 | Buy | $410.00 | +22.53% | Maintains | 3 months ago |
Vaxcyte IncPCVX | 1 | Buy | $60.00 | +59.11% | Initiates Coverage On | 3 months ago |
Horizon Therapeutics Public Ltd CoHZNP | 7 | Hold | $116.50 | +6.71% | Downgrades | 3 months ago |
Theravance Biopharma IncTBPH | 2 | Buy | $14.00 | +29.75% | Maintains | 4 months ago |
Radius Health IncRDUS | 2 | Hold | $10.00 | -0.79% | Maintains | 9 months ago |
Hillevax IncHLVX | 1 | Buy | $30.00 | +93.67% | Initiates Coverage On | 10 months ago |
Organon & CoOGN | 1 | Hold | $33.00 | N/A | Initiates Coverage On | 2 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $62.00 | N/A | Downgrades | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Hold | $176.00 | N/A | Maintains | 2 years ago |
Viatris IncVTRS | 1 | Hold | $16.00 | N/A | Maintains | 2 years ago |
Perrigo Co PLCPRGO | 5 | Hold | $45.00 | N/A | Maintains | 2 years ago |
Endo International PLCENDPQ | 2 | Strong Sell | $7.00 | N/A | Maintains | 2 years ago |
Bausch Health Companies IncBHC | 1 | Hold | $35.00 | N/A | Maintains | 2 years ago |
Elanco Animal Health IncELAN | 2 | Strong Buy | $31.00 | N/A | Upgrades | 3 years ago |
Royalty Pharma PLCRPRX | 1 | Hold | $51.00 | N/A | Initiates Coverage On | 3 years ago |
Zoetis IncZTS | 2 | Hold | $125.00 | N/A | Maintains | 3 years ago |
Teva Pharmaceutical Industries LtdTEVA | 7 | Strong Sell | $8.00 | N/A | Maintains | 3 years ago |
Merck & Co IncMRK | 6 | Strong Buy | $89.00 | N/A | Maintains | 3 years ago |
Alkermes PLCALKS | 1 | Hold | $16.00 | N/A | Maintains | 3 years ago |
Allergan PLCAGN | 6 | Hold | $156.00 | N/A | Downgrades | 4 years ago |
Amneal Pharmaceuticals IncAMRX | 1 | Hold | $18.00 | N/A | Downgrades | 4 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.